Clinical trial

Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors

NCT00116857 · Washington University School of Medicine, Other · Completed

Key facts

NCT number NCT00116857
Title Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors
Official title Omega-3 for Depression and Other Cardiac Risk Factors
Lead sponsor Washington University School of Medicine, Other
Collaborators National Heart, Lung, and Blood Institute (NHLBI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Cardiovascular Diseases, Depression, Heart Diseases, Myocardial Infarction, Angina, Unstable
Intervention type Drug
Interventions Sertraline/omega-3, Sertraline/Corn Oil
Enrollment 122
Start date Feb 1, 2005
Primary completion Jun 1, 2009
Completion Nov 1, 2009
First posted Jul 1, 2005
Last update posted Sep 12, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies